Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples